Investigating Potential Claims – Alliqua Biomedical Inc.
Are you concerned about your investment in Alliqua Biomedical Inc.? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
According to its website, Alliqua BioMedical (NASDAQ: ALQA) develops and manufactures electron-beam cross-linked sheet gels for customers that include manufacturers of medical devices, cosmeceuticals, and other commercial product applications.
According to SEC filings, Alliqua has filed several Regulation D Private Placements to raise capital from investors in New York, NY beginning in 2010. The company is formerly known as Alliqua Inc., and prior to that, Hepalife Technologies, Inc.
Investments such as these are typically sold by brokerage firms in exchange for a large up front commission. High fees can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%.
The problem with private placement investments such as Alliqua Inc. is that they typically involve a high degree of risk. They are also often sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks or bonds.
Are Private Placement Investments Suitable for you?
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for unsuitably recommending high-risk private placements, like Alliqua, to investors.
Despite the risks of investing in private placements, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
If you have concerns regarding your investment in Alliqua Inc. and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visithttps://whitesecuritieslaw.com.
Tags: Alliqua Biomedical class action, Alliqua Biomedical investigation, Alliqua Biomedical lawsuit, Alliqua Biomedical losses, Alliqua Biomedical stock info, Alliqua Inc. complaints, Alliqua Inc. help, Alliqua Inc. high commissions, Alliqua Inc. information, Alliqua Inc. investigation, Alliqua Inc. investment, Alliqua Inc. investment losses, Alliqua Inc. investor relations, Alliqua Inc. investors, Alliqua Inc. losses, Alliqua Inc. ppm, Alliqua Inc. private placement, Alliqua Inc. prospectus, Alliqua Inc. real estate, Alliqua Inc. recovery options, Alliqua Inc. risk, Alliqua Inc. stock information, Alliqua Inc. update, Hepalife Technologies Last modified: May 10, 2018